Thrombophilia, risk factors and prevention

E Campello, L Spiezia, A Adamo… - Expert review of …, 2019 - Taylor & Francis
Introduction: Fifty-three years after the first description of an inherited prothrombotic
condition (antithrombin deficiency), our knowledge on hereditary and acquired causes of …

Genetic risk factors for venous thromboembolism

B Zöller, PJ Svensson, B Dahlbäck… - Expert Review of …, 2020 - Taylor & Francis
Introduction Venous thromboembolism (VTE) is a complex disease that aggregates in
families. Both acquired and genetic risk factors are important. Proper recognition and …

Inherited risk factors for venous thromboembolism

I Martinelli, V De Stefano, PM Mannucci - Nature Reviews Cardiology, 2014 - nature.com
Venous thromboembolism (VTE) has important heritable components. In the past 20 years,
knowledge in this field has greatly increased with the identification of a number of gene …

Genetics of venous thrombosis: update in 2015

PE Morange, P Suchon… - Thrombosis and …, 2015 - thieme-connect.com
Venous thrombosis (VT) is a common multifactorial disease with a genetic component that
was first suspected nearly 60 years ago. In this review, we document the genetic …

Snake venoms in diagnostic hemostasis and thrombosis

GW Moore - Seminars in thrombosis and hemostasis, 2022 - thieme-connect.com
Snake venoms have evolved primarily to immobilize and kill prey, and consequently, they
contain some of the most potent natural toxins. Part of that armory is a range of hemotoxic …

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia

P Simioni, S Cagnin, F Sartorello… - Blood, The Journal …, 2021 - ashpublications.org
High coagulation factor VIII (FVIII) levels comprise a common risk factor for venous
thromboembolism (VTE), but the underlying genetic determinants are largely unknown. We …

Diagnosis and management of factor V Leiden

E Campello, L Spiezia, P Simioni - Expert review of hematology, 2016 - Taylor & Francis
Introduction: The discovery of the factor V Leiden (FVL) missense mutation (Arg506Gln)
causing factor V resistance to the anticoagulant action of activated protein C was a landmark …

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

DA Trégouët, PE Morange - British journal of haematology, 2018 - Wiley Online Library
Venous thromboembolism (VTE) has a strong genetic component. This review summarizes
what is known at the seventeen genes that are now well established to harbour VTE …

New prothrombin mutation (Arg596Trp, prothrombin Padua 2) associated with venous thromboembolism

C Bulato, CM Radu, E Campello… - … and Vascular Biology, 2016 - Am Heart Assoc
Objective—Two different prothrombin variants, p. Arg596Leu and p. Arg596Gln, conferring
antithrombin resistance to patients with venous thromboembolism have been recently …

Vitamin K-dependent coagulation factors that may be responsible for both bleeding and thrombosis (FII, FVII, and FIX)

A Girolami, S Ferrari, E Cosi… - Clinical and Applied …, 2018 - journals.sagepub.com
Vitamin K-dependent clotting factors are commonly divided into prohemorrhagic (FII, FVII,
FIX, and FX) and antithrombotic (protein C and protein S). Furthermore, another protein …